STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2019

STOCKHOLDERS' EQUITY

Schedule of BSM using weighted-average assumptions

These fair values were derived using the BSM with the following weighted-average assumptions:

	For the Years Ended December 31,
	2019		2018
Average risk-free interest rate	1.84	%	2.42	%
Expected dividend yield	0.00	%	0.00	%
Expected lives	5.25 years		6.00 years
Expected volatility	68.0	%	65.1	%

Schedule of Share-based Compensation, Stock Options, Activity

Transactions and other information relating to stock options for the years December 31, 2019 and 2018 are summarized below:

				Weighted-
				Average
		Weighted-		Remaining
	Number	Average		Contractual	Aggregate
	of	Exercise		Term	Intrinsic
	Options	Price		(In Years)	Value
Outstanding at December 31, 2017	4,804,000	$	1.89	4.90	$	795,000
Grants	733,000	$	1.81
Exercised	63,000	$	1.41
Forfeited/cancelled/expired/settled	(1,905,000)	$	1.43
Outstanding at December 31, 2018	3,569,000	$	2.12	7.19	$	130,000
Grants	653,000	$	2.17
Exercised	15,000	$	1.90
Forfeited/cancelled/expired/settled	(10,000)	$	1.90
Outstanding at December 31, 2019	4,197,000	$	2.13	6.70	$	255,000
Vested and expected to vest at December 31, 2019	4,145,000	$	2.13	6.68	$	255,000
Unvested at December 31, 2019	822,000	$	2.11	9.13	$	—
Exercisable at December 31, 2019	3,375,000	$	2.13	6.11	$	255,000

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

Transactions and other information relating to restricted stock grants for the years ended December 31, 2019 and 2018 are summarized below:

		Average
		Fair
		Value at
		Grant
	Shares	Date
Unvested at December 31, 2017	2,303,000	$	1.94
Grants	1,758,000	$	1.83
Vested	(1,904,000)	$	1.93
Forfeited/cancelled/expired	(33,000)	$	1.90
Unvested at December 31, 2018	2,124,000	$	1.85
Grants	2,604,000	$	2.16
Vested	(2,840,000)	$	1.94
Forfeited/cancelled/expired	(74,000)	$	2.19
Unvested at December 31, 2019	1,814,000	$	2.14